2017
DOI: 10.1186/s40337-017-0149-z
|View full text |Cite|
|
Sign up to set email alerts
|

Burden and health-related quality of life of eating disorders, including Avoidant/Restrictive Food Intake Disorder (ARFID), in the Australian population

Abstract: BackgroundLittle is known about the epidemiology and health related quality of life (HRQoL) of the new DSM-5 diagnoses, Binge Eating Disorder (BED) and Avoidant/Restrictive Food Intake Disorder (ARFID) in the Australian population. We aimed to investigate the prevalance and burden of these disorders.MethodsWe conducted two sequential population-based surveys including individuals aged over 15 years who were interviewed in 2014 (n = 2732) and 2015 (n =3005). Demographic information and diagnostic features of DS… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

7
188
5
3

Year Published

2018
2018
2021
2021

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 239 publications
(203 citation statements)
references
References 29 publications
7
188
5
3
Order By: Relevance
“…Second, we used an elevated EDE‐Q global score as a marker of elevated eating disorder psychopathology, but this is not a specific indicator of the psychopathology needed for diagnosis. Furthermore, because the EDE‐Q fails to capture the associated features of binge‐eating episodes, the prevalence of clinically significant binge eating would likely be overestimated in our study (Binford, Le Grange, & Jellar, ; Goldfein, Devlin, & Kamenetz, ; Hay et al, ; Mitchison, Touyz, Gonzalez‐Chica, Stocks, & Hay, ), although not all studies find that the EDE‐Q over identifies objective binge‐eating episodes (Grilo, Masheb, & Wilson, ; Mond et al, ). Overall, false positives included in our sample would have resulted in exaggerated estimates of under‐diagnosis and under‐treatment.…”
Section: Discussionmentioning
confidence: 77%
“…Second, we used an elevated EDE‐Q global score as a marker of elevated eating disorder psychopathology, but this is not a specific indicator of the psychopathology needed for diagnosis. Furthermore, because the EDE‐Q fails to capture the associated features of binge‐eating episodes, the prevalence of clinically significant binge eating would likely be overestimated in our study (Binford, Le Grange, & Jellar, ; Goldfein, Devlin, & Kamenetz, ; Hay et al, ; Mitchison, Touyz, Gonzalez‐Chica, Stocks, & Hay, ), although not all studies find that the EDE‐Q over identifies objective binge‐eating episodes (Grilo, Masheb, & Wilson, ; Mond et al, ). Overall, false positives included in our sample would have resulted in exaggerated estimates of under‐diagnosis and under‐treatment.…”
Section: Discussionmentioning
confidence: 77%
“…Since ARFID is a relatively new diagnosis, there have only been two population-based prevalence studies. An Australian interview-based study of males and females ages 15 and older reported a 3-month point prevalence of ARFID of 0.3% in 2013 and in 2014 (7). A study of schoolchildren ages 8–13 in Switzerland reported a point prevalence of 3.2% measured via self-report questionnaire (8).…”
Section: What Is Known About Arfid?mentioning
confidence: 99%
“…Several measures assessing picky or selective eating in population samples are also available (e.g.,Wardle, Guthrie, Sanderson, & Rapoport, ; Pliner & Hobden, —see Table for additional measures) but all are too broad to measure ARFID psychopathology specifically. Whereas selective or picky eating is common in community samples (Wildes, Zucker, & Marcus, ), the psychiatric disorder ARFID has been shown to be far less common (Hay et al, ; Kurz, Van Dyck, Dremmel, Munsch, & Hilbert, ). However, prevalence studies of ARFID have to date relied on self‐report measures (Kurz et al, ) or unvalidated clinical interviews (Hay et al, ), making it challenging to ascertain the frequency of ARFID in the general population.…”
Section: Introductionmentioning
confidence: 99%
“…Whereas selective or picky eating is common in community samples (Wildes, Zucker, & Marcus, ), the psychiatric disorder ARFID has been shown to be far less common (Hay et al, ; Kurz, Van Dyck, Dremmel, Munsch, & Hilbert, ). However, prevalence studies of ARFID have to date relied on self‐report measures (Kurz et al, ) or unvalidated clinical interviews (Hay et al, ), making it challenging to ascertain the frequency of ARFID in the general population. Indeed, available estimates range widely, from 0.3% by clinical interview in an epidemiological study of Australian adults (Hay et al, ), to 3.2% by self‐report survey among Swiss schoolchildren ages 8–13 years old (Kurz et al, ).…”
Section: Introductionmentioning
confidence: 99%